"investing"

Current assumption is whoever builds the smartest model will control the future of AI. Recent events suggest a different possibility.

Eli Lilly's acquisition of AtaiBeckley for up to $3.8 billion, marks a pivotal moment for psychedelic medicine.

Hackers switch their prompts to less common natural languages to avoid AI safety features. AI makers are coping with it

Here are hints and answers for the NYT Strands puzzle for July 12, No. 861.

The real story is that we're approaching the ability to read, interpret and eventually intervene in the human body's operating system.

The sun supports all life on Earth. But its 'solar tsunamis' threaten our electricity infrastructure. Discover how New Zealand is preparing...

Anthropic and other AI makers are pursuing the use of AI to advance AI. It's dicey. Even more so when it comes to AI for mental health. An A...

The less than two-year old startup crossed $400 million in annual recurring revenue earlier this year. The new fundraise would almost double...

SpaceX has officially filed for its historic IPO. Discover the key details investors need to know about its valuation, revenue, and core ris...

Telling the model to behave does not work. Probabilistic systems do not yield deterministic security outcomes, no matter how carefully the s...

This week’s Current Climate newsletter also looks at how the U.S. EV market is about to get quirkier and the bipartisan appeal of recycling.

The streaming video company with the world's most subscribers has leaned quickly into AI-assisted production.